San Diego, CA, United States of America

Farah Hedjran

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • La Jolla, CA (US) (2018)
  • San Diego, CA (US) (2015 - 2023)

Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Farah Hedjran: Innovator in Tumor-Selective Gene Therapy

Introduction

Farah Hedjran is a prominent inventor based in San Diego, CA (US). She has made significant contributions to the field of gene therapy, particularly in developing tumor-selective expression systems. With a total of 5 patents, her work has the potential to revolutionize cancer treatment.

Latest Patents

Hedjran's latest patents focus on tumor-selective E1a and E1b mutants. These patents provide modified E1a regulatory sequences, wherein at least one Pea3 binding site, or a functional portion thereof, is deleted. Additionally, modified E1a sequences that selectively express particular isoforms are included. An E1b-19K clone insertion site is also provided. These modified sequences can be utilized individually or in combination to achieve tumor-selective expression of proteins.

Career Highlights

Throughout her career, Farah has worked at the University of California, where she has contributed to various research projects. Her innovative approaches have garnered attention in the scientific community, leading to her recognition as a leading inventor in her field.

Collaborations

Farah has collaborated with notable individuals such as Tony R Reid and Shantanu Kumar. These partnerships have further enhanced her research and development efforts in gene therapy.

Conclusion

Farah Hedjran's work in tumor-selective gene therapy exemplifies her commitment to advancing medical science. Her innovative patents and collaborations position her as a key figure in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…